» Articles » PMID: 36951981

An Implantable Shock Absorber Yields an 85% Survival-from-arthroplasty Rate Through 5 years in Working-age Patients with Medial Compartment Knee Osteoarthritis

Overview
Publisher Wiley
Date 2023 Mar 23
PMID 36951981
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the 5-year rate of survival without undergoing arthroplasty or high tibial osteotomy (HTO) in subjects with mild-to-moderate medial compartment knee osteoarthritis (OA) who were treated with an implantable shock absorber (ISA) system.

Methods: Three prospective, sequential, multicenter, international, single-arm clinical trials were conducted comprising subjects who received an ISA for symptomatic medial knee OA after failing ≥ 6 months of conservative therapy. Study outcomes were analyzed cumulatively and by enrollment group when all subjects' follow-up data exceeded the 2-year threshold after ISA implantation. Primary outcome was survival rate without conversion to arthroplasty/HTO. Secondary outcomes were changes in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores after ISA implantation.

Results: All 171 enrolled subjects (age 51 ± 9 years, body-mass index 28.5 ± 3.5 kg/m, 38% female; study knee Kellgren-Lawrence score 2.7 ± 0.9 points) were followed for a minimum of 2, and up to 5, years after device implantation. Overall, 90.6% (155/171) of subjects survived without requiring arthroplasty/HTO at last follow-up (mean 3.2 ± 1.6 years). The Kaplan-Meyer median 3- and 5-year survival-without-arthroplasty point estimates were 89.8% (95% CI 86.5‒95.7%) and 84.9% (95% CI 75.1‒91.1%), respectively. The median 3-year estimated survival rate for the most recent study (n = 81) was 97.3%. The mean WOMAC Pain score decreased 71% from baseline to last follow-up after ISA implantation, from 58 ± 13 to 16 ± 17 points (p < 0.0001). The Function score improved 69%, decreasing from 56 ± 18 to 17 ± 17 points (p < 0.0001).

Conclusions: In younger patients with mild-to-moderate symptomatic medial compartment knee OA, implantation of the ISA device resulted in a 5-year survival rate of 85% from undergoing arthroplasty or HTO. The ISA system may be an effective treatment option for working-age patients with medial knee OA who are not candidates for or do not desire more invasive surgical approaches.

Level Of Evidence: II.

Citing Articles

Medial Meniscus Root Repair With Implantable Shock Absorber Placement: A Combined Technique for Early Partial Weightbearing.

Neijna A, Huddleston H, Gomoll A, Strickland S Arthrosc Tech. 2025; 14(1):103162.

PMID: 39989686 PMC: 11843291. DOI: 10.1016/j.eats.2024.103162.

References
1.
Altman R, Gold G . Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage. 2007; 15 Suppl A:A1-56. DOI: 10.1016/j.joca.2006.11.009. View

2.
Bayliss L, Culliford D, Monk A, Glyn-Jones S, Prieto-Alhambra D, Judge A . The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet. 2017; 389(10077):1424-1430. PMC: 5522532. DOI: 10.1016/S0140-6736(17)30059-4. View

3.
Bellamy N, BUCHANAN W, Goldsmith C, Campbell J, Stitt L . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-40. View

4.
Bode G, Kloos F, Feucht M, Fleischer B, Sudkamp N, Niemeyer P . Comparison of the efficiency of an extra-articular absorber system and high tibial osteotomy for unloading the medial knee compartment: an in vitro study. Knee Surg Sports Traumatol Arthrosc. 2016; 25(12):3695-3703. DOI: 10.1007/s00167-016-4358-9. View

5.
Brown G . AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013; 21(9):577-9. DOI: 10.5435/JAAOS-21-09-577. View